Literature DB >> 32248732

Mutations of RNF213 are responsible for sporadic cerebral cavernous malformation and lead to a mulberry-like cluster in zebrafish.

Jing Lin1, Jie Liang1, Jun Wen2, Man Luo3, Jiaoxing Li1, Xunsha Sun1, Xiaowei Xu4, Jianli Li3, Dongxian Wang5, Jie Wang5, Huimin Chen1, Rong Lai1, Fengyin Liang1, Chuan Li5, Fei Ye1, Jingjing Zhang6, Jinsheng Zeng1, Shulan Yang5, Wenli Sheng1.   

Abstract

Although familial forms of cerebral cavernous malformation are mainly attributed to three CCM genes (KRIT1, CCM2 and PDCD10), no mutation is identified in sporadic cerebral cavernous malformation cases with a unique lesion, indicating additional genes for sporadic cerebral cavernous malformation. To screen the candidate genes, we conducted whole exome sequencing in 31 sporadic cerebral cavernous malformation patients and 32 healthy controls, and identified 5 affected individuals carrying 6 heterozygous deleterious mutations in RNF213 but no RNF213 mutation in healthy individuals. To further confirm RNF213 was associated with cerebral cavernous malformation, we generated rnf213a homozygous knockout zebrafish and found mutation of rnf213a in zebrafish led to a mulberry-like cluster of disordered-flow vascular channels which was reminiscent of human cerebral cavernous malformation. In addition, we revealed kbtbd7 and anxa6 were significantly downregulated due to rnf213a mutation through transcriptomic sequencing and RT-qPCR analysis. Based on the mulberry-like phenotype partly rescued by mRNA of kbtbd7 as well as anxa6, we suggested that rnf213a promoted mulberry-like cluster via downregulation of kbtbd7 and anxa6. Altogether, we firstly demonstrate RNF213is a novel candidate gene for sporadic cerebral cavernous malformation and the mutation of rnf213a is responsible for the mulberry-like cluster in zebrafish.

Entities:  

Keywords:  RNF213 mutation; Sporadic cerebral cavernous malformation; mulberry-like cluster; rnf213a; zebrafish

Year:  2020        PMID: 32248732      PMCID: PMC8142133          DOI: 10.1177/0271678X20914996

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  39 in total

1.  A genome-wide association study identifies RNF213 as the first Moyamoya disease gene.

Authors:  Fumiaki Kamada; Yoko Aoki; Ayumi Narisawa; Yu Abe; Shoko Komatsuzaki; Atsuo Kikuchi; Junko Kanno; Tetsuya Niihori; Masao Ono; Naoto Ishii; Yuji Owada; Miki Fujimura; Yoichi Mashimo; Yoichi Suzuki; Akira Hata; Shigeru Tsuchiya; Teiji Tominaga; Yoichi Matsubara; Shigeo Kure
Journal:  J Hum Genet       Date:  2010-11-04       Impact factor: 3.172

2.  Genotype-phenotype correlations in cerebral cavernous malformations patients.

Authors:  Christian Denier; Pierre Labauge; Françoise Bergametti; Florence Marchelli; Florence Riant; Minh Arnoult; Jacqueline Maciazek; Eric Vicaut; Laurent Brunereau; Elisabeth Tournier-Lasserve
Journal:  Ann Neurol       Date:  2006-11       Impact factor: 10.422

3.  The vascular anatomy of the developing zebrafish: an atlas of embryonic and early larval development.

Authors:  S Isogai; M Horiguchi; B M Weinstein
Journal:  Dev Biol       Date:  2001-02-15       Impact factor: 3.582

4.  The R306G and R506Q mutations in coagulation Factor V reveals additional cleavage sites for Activated Protein C in the R313-R321 region and at R505.

Authors:  Richard J Dirven; Hans L Vos; Rogier M Bertina
Journal:  Thromb Res       Date:  2010-01-03       Impact factor: 3.944

Review 5.  Recent insights into cerebral cavernous malformations: animal models of CCM and the human phenotype.

Authors:  Aubrey C Chan; Dean Y Li; Michel J Berg; Kevin J Whitehead
Journal:  FEBS J       Date:  2010-01-22       Impact factor: 5.542

6.  Mutation of rnf213a by TALEN causes abnormal angiogenesis and circulation defects in zebrafish.

Authors:  Jun Wen; Xunsha Sun; Huimin Chen; Huijiao Liu; Rong Lai; Jiaoxing Li; Yufang Wang; Jingjing Zhang; Wenli Sheng
Journal:  Brain Res       Date:  2016-04-26       Impact factor: 3.252

7.  Functional analyses of human and zebrafish 18-amino acid in-frame deletion pave the way for domain mapping of the cerebral cavernous malformation 3 protein.

Authors:  Katrin Voss; Sonja Stahl; Benjamin M Hogan; Joerg Reinders; Elisa Schleider; Stefan Schulte-Merker; Ute Felbor
Journal:  Hum Mutat       Date:  2009-06       Impact factor: 4.878

8.  Gelatinolytic activity of autocrine matrix metalloproteinase-9 leads to endothelial de-arrangement in Moyamoya disease.

Authors:  Kinga G Blecharz-Lang; Vincent Prinz; Małgorzata Burek; Dietmar Frey; Tobias Schenkel; Susanne M Krug; Michael Fromm; Peter Vajkoczy
Journal:  J Cereb Blood Flow Metab       Date:  2018-04-10       Impact factor: 6.200

9.  Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development.

Authors:  Wanyang Liu; Daisuke Morito; Seiji Takashima; Yohei Mineharu; Hatasu Kobayashi; Toshiaki Hitomi; Hirokuni Hashikata; Norio Matsuura; Satoru Yamazaki; Atsushi Toyoda; Ken-ichiro Kikuta; Yasushi Takagi; Kouji H Harada; Asao Fujiyama; Roman Herzig; Boris Krischek; Liping Zou; Jeong Eun Kim; Masafumi Kitakaze; Susumu Miyamoto; Kazuhiro Nagata; Nobuo Hashimoto; Akio Koizumi
Journal:  PLoS One       Date:  2011-07-20       Impact factor: 3.240

10.  High mutation detection rates in cerebral cavernous malformation upon stringent inclusion criteria: one-third of probands are minors.

Authors:  Stefanie Spiegler; Juliane Najm; Jian Liu; Stephanie Gkalympoudis; Winnie Schröder; Guntram Borck; Knut Brockmann; Miriam Elbracht; Christine Fauth; Andreas Ferbert; Leonie Freudenberg; Ute Grasshoff; Yorck Hellenbroich; Wolfram Henn; Sabine Hoffjan; Irina Hüning; G Christoph Korenke; Peter M Kroisel; Erdmute Kunstmann; Martina Mair; Susanne Munk-Schulenburg; Omid Nikoubashman; Silke Pauli; Sabine Rudnik-Schöneborn; Irene Sudholt; Ulrich Sure; Sigrid Tinschert; Michaela Wiednig; Barbara Zoll; Mark H Ginsberg; Ute Felbor
Journal:  Mol Genet Genomic Med       Date:  2014-01-14       Impact factor: 2.183

View more
  3 in total

Review 1.  Novel Multifaceted Roles for RNF213 Protein.

Authors:  Giuliana Pollaci; Gemma Gorla; Antonella Potenza; Tatiana Carrozzini; Isabella Canavero; Anna Bersano; Laura Gatti
Journal:  Int J Mol Sci       Date:  2022-04-19       Impact factor: 6.208

2.  EZH2 Regulates ANXA6 Expression via H3K27me3 and Is Involved in Angiotensin II-Induced Vascular Smooth Muscle Cell Senescence.

Authors:  Yuejin Li; Shikui Guo; Yingpeng Zhao; Rougang Li; Yu Li; Changtao Qiu; Le Xiao; Kunmei Gong
Journal:  Oxid Med Cell Longev       Date:  2022-09-14       Impact factor: 7.310

3.  A new syndrome of moyamoya disease, kidney dysplasia, aminotransferase elevation, and skin disease associated with de novo variants in RNF213.

Authors:  Alanna Strong; Gina O'Grady; Evelyn Shih; Jonathan R Bishop; Kathleen Loomes; Tamir Diamond; Erum A Hartung; William Wong; Sanmati Cuddapah; Anne Marie Cahill; Cuiping Hou; Diana Slater; Courtney Vaccaro; Deborah Watson; Dong Li; Hakon Hakonarson
Journal:  Am J Med Genet A       Date:  2021-05-07       Impact factor: 2.802

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.